Advertisement

Topics

SONAR trial data shows atrasentan use beneficial in diabetes, CKD

06:31 EDT 16 Apr 2019 | SmartBrief

Results from the late-stage international SONAR trial, involving over 11,000 patients from 41 countries, showed a 35% reducti -More

Original Article: SONAR trial data shows atrasentan use beneficial in diabetes, CKD

NEXT ARTICLE

More From BioPortfolio on "SONAR trial data shows atrasentan use beneficial in diabetes, CKD"

Advertisement
Quick Search
Advertisement
Advertisement